View Clinical Trial (Medical Research Study)


Screening Protocol for Subjects Being Evaluated for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Protocols

Signup
Browse Studies

City:   Bethesda
State:   Maryland
Zip Code:   20892
Conditions:   Inflammatory Disease - Autoimmune Disease - Immunologic Disease - Healthy Volunteers
Purpose:   Background: - For every CHI research study, patients must fulfill a list of criteria, based primarily on their medical condition. To determine whether a patient meets these eligibility criteria to participate in a research protocol, researchers must perform a series of diagnostic tests and procedures. - These evaluations are designed to evaluate a participant s general medical condition (i.e., blood tests, function of certain organs such as the lungs, heart, liver, or kidneys), and to confirm a diagnosis or ensure that a healthy volunteer is in good condition. They maximize the safety for the patients and healthy volunteers at CHI. Objective: - To determine the eligibility of patients and healthy volunteers for active CHI research protocols. Eligibility: - The procedures included in this protocol will determine eligibility for active CHI research protocols. - Both healthy volunteers and patients will be evaluated. Design: - Required tests and procedures for various research studies may include the following: history and physical examination, blood and urine tests, lung and heart function tests (echocardiogram, electrocardiogram, stress test), imaging studies (X-rays, magnetic resonance imaging (MRI), computerized tomography (CT), and tissue collection. - Participants will be asked to undergo tests only for the study or studies for which they are being considered. The research team will provide further information on any additional tests that may be required. - After all eligibility assessments are complete, participants may be offered participation in one or more CHI research protocols or referred back to a home physician.
Study Summary:   This protocol is designed for screening of subjects prior to a decision as to their eligibility for participation on a Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) tissue procurement or investigative therapy protocol. The purpose of the protocol is to allow investigation into any underlying immunologic and/or inflammatory processes and to assess the status of organ systems, important both to determine suitability for participation on specific protocols and/or ability to safely tolerate tissue procurement or investigative treatments and procedures. It also allows the investigation as to whether subjects are eligible for participation as a volunteer based on eligibility criteria that include generally good health status by history and physical examination and laboratory assessment. After completion of the screening process, the subject will either be offered an opportunity to participate in a specific research protocol, or if no appropriate protocol is identified, will have recommendations for other treatment options conveyed to the primary or referring physician. Primary objective is to determine subject eligibility for participation on Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) tissue procurement or investigative therapy protocols. Primary endpoint is the results of clinical, imaging and laboratory assessments.
Criteria:   - INCLUSION CRITERIA: 1. Diagnosed with a disorder for which the CHI has an active research protocol, and based on information received from an outside physician, the patient appears to meet at least preliminary eligibility criteria for that protocol. OR Self proclaimed healthy volunteer for whom the CHI has a study actively recruiting healthy volunteers and he/she appears to meet preliminary eligibility as a healthy volunteer. 2. Age greater than or equal to 2 (healthy volunteers greater than or equal to 8) 3. Weight greater than 12 kg 4. The subject or the subject s guardian is capable of informed consent, and willing to sign the consent form after initial counseling by clinical staff. Separate consent forms for all interventional or surgical procedures will be obtained after explanation of the specific procedure. EXCLUSION CRITERIA: All subjects not fulfilling the inclusion criteria will be considered ineligible.
NCT ID:   NCT00968084
Primary Contact:   Principal Investigator
Neal S Young, M.D.
National Heart, Lung, and Blood Institute (NHLBI)

Kinneret S Broder
Phone: (301) 402-2837
Email: broderk@mail.nih.gov
Backup Contact:   Email: youngns@mail.nih.gov
Neal S Young, M.D.
Phone: (301) 496-5093
Location Contact:   Bethesda, Maryland 20892
United States

For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL)
Phone: 800-411-1222
Email: prpl@mail.cc.nih.gov

Site Status: Recruiting

Data Source:   ClinicalTrials.gov
Date Processed:   April 18, 2015
Modifications to this listing:   Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


  • NEARBY STUDIES

    (updated 1 minute ago)
Within 25 Miles

Dry Eye - Mc Lean VA

Smoking Cessation - College Park MD

Ulcerative Colitis - Chevy Chase MD

Crohn's Disease - Chevy Chase MD

Alzheimer’s Disease - Washington DC

Adolescent Major Depression (Ages 12-17) - Washington DC

Multiple Sclerosis - Washington DC

Healthy Volunteers - NY, NJ, PA, DE, DC, MD or VA

Polycystic Kidney Disease (PKD) - Autosomal Dominant (ADPKD) - Arlington VA

Healthy Volunteers - Rockville MD

Adolescent Major Depression (Ages 12-17) - Rockville MD

Polycystic Kidney Disease (PKD) - Autosomal Dominant (ADPKD) - Bethesda MD

Diabetic Kidney Disease - Rockville MD

Diabetic Kidney Disease - Fairfax VA

Birth Control Patch - Rockville MD

Psoriasis - NY, NJ, PA, DE, DC, MD or VA

Flu Vaccine - Rockville MD

Blood Donation For Any Diseases - NY, NJ, PA, DE, DC, MD or VA

Major Depressive Disorder - Rockville MD

Autism - Rockville MD

Multiple Sclerosis - Fulton MD

Adult Autism - Rockville MD

Healthy Volunteers (Ages 18-45 - Malaria Vaccine) - Silver Spring, MD

Healthy Volunteers (Ages 18-49) - Silver Spring, MD

Healthy Volunteers (Ages 18-49) - Dengue Vaccine - Silver Spring MD

Healthy Volunteers (Ages 18-49 - Hantavirus Vaccine) - Silver Spring, MD

Non-small Lung Cancer (NSCLC) - Rockville MD

High Cholesterol - Oxon Hill MD

Within 50 Miles

Diabetic Foot Ulcers (Sores) - Pasadena MD

Crohn's Disease - Annapolis MD

Adolescent Major Depression (Ages 12-17) - Baltimore MD

Temporomandibular Disorder (TMJD) - Baltimore MD

Healthy Volunteers (Age 18-49) - Baltimore MD

Healthy Female Volunteers (Age 18-39) - Baltimore MD

Stress Urinary Incontinence (SUI) - Glen Burnie MD

Healthy Volunteers (Age 18-65) - Baltimore MD

Polycystic Kidney Disease (PKD) - Autosomal Dominant (ADPKD) - Baltimore MD

Asthma - Towson MD

Herpes - Towson MD

Healthy Volunteers (Age 18-35) - Baltimore MD

Healthy Volunteers (Age 18-45) - Baltimore MD

Allergies - Baltimore MD

Eczema - Baltimore MD

Heart Attack - Towson MD

Healthy Volunteers (Age 50-80) - Baltimore MD

Healthy Volunteers (Age 25-80) - Baltimore MD

Healthy Volunteers (Age 18-55) - Baltimore MD

Healthy Volunteers (Age 18-45) - Baltimore MD

Adult Autism - Baltimore MD

Healthy Volunteers (Age 18-45) - Baltimore MD

Healthy Volunteers (Age 18-50) - Baltimore MD

Post Menopause - Baltimore MD

Spinal Cord Injury - Baltimore MD

Healthy NON-Smokers - Catonsville MD

Within 100 Miles

Leukemia or Lymphoma - Hershey PA

Asthma - Henrico VA

Adolescent Major Depression (Ages 12-17) - Richmond VA

Dust Mite Allergy - Henrico VA

Severe Asthma - Richmond VA

Children with Asthma - Richmond VA

Endometriosis - Richmond VA

COPD (Emphysema and Chronic Bronchitis) - Richmond VA

Pediatric Depression - Richmond VA